Gilead Sciences Announces First Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. ENOV
4. AON
5. AZN
6. BLSM
7. KRMN
8. GRMN
9. GPRO
10. VRSK

Go back to Gilead Sciences Announces First Quarter 2021 Financial Results

Gilead Sciences (GILD) Misses Q1 EPS by 1c

April 29, 2021 4:02 PM EDT

Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $2.08, $0.01 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $6.4 billion versus the consensus estimate of $6.74 billion.

We have made strong progress in this first quarter, with our new partnership with Merck in long-acting HIV therapies, two newly approved indications in the U.S. for Trodelvy in metastatic triple-negative breast cancer and metastatic urothelial cancer, and the... More